Nallamothu Geetha, Hilden Kristen, Adler Douglas G
Division of Gastroenterology and Hepatology, University of Utah School of Medicine, Huntsman Cancer Center, Salt Lake City, UT 84312, USA.
Hosp Pract (1995). 2011 Apr;39(2):70-80. doi: 10.3810/hp.2011.04.396.
Endoscopic retrograde cholangiopancreatography (ERCP) represents the most powerful and widely employed platform for pancreaticobiliary interventions. Endoscopic retrograde cholangiopancreatography allows diagnosis and treatment of a broad spectrum of diseases of the pancreaticobiliary tree that are both benign and malignant in nature. Endoscopic retrograde cholangiopancreatography continues to evolve rapidly, and non-gastroenterologists need to understand the indications, contraindications, limitations, and role of ERCP to effectively manage and coordinate the care of patients with known or suspected pancreaticobiliary disease. This article will review the role of ERCP in detail to further an understanding of the procedure as a whole and to assess when referral of a patient for an ERCP or other related test is indicated.
内镜逆行胰胆管造影术（ERCP）是用于胰胆管介入治疗最强大且应用最广泛的平台。内镜逆行胰胆管造影术能够诊断和治疗胰胆管系统的多种疾病，这些疾病包括良性和恶性的。内镜逆行胰胆管造影术仍在迅速发展，非胃肠病学专家需要了解其适应证、禁忌证、局限性以及在已知或疑似胰胆管疾病患者的有效管理和护理协调中的作用。本文将详细回顾内镜逆行胰胆管造影术的作用，以进一步全面了解该操作，并评估何时应将患者转诊进行内镜逆行胰胆管造影术或其他相关检查。
